Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

ELSE vs KEQU: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

KEQU Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 6–4 Matrix Metrics)

KEQU Overall Winner 6-Pillar Tally: ELSE 1 – 4 KEQU (1 Tie) Matrix Metrics: ELSE 4 – 6 KEQU

As of Nov 20, 2026, Kewaunee Scientific Corp (KEQU) is the stronger overall head-to-head candidate over Electro-Sensors Inc (ELSE) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ELSE carries a Unified Composite Score of 57.3/100 (HOLD) at $7.74 (14.7x Forward P/E, -8.5% operating margin), whereas KEQU carries 37.8/100 (SELL) at $33.55 (7.7x Forward P/E, 5.4% operating margin).

  • Composite vs. Pillar Nuance: While ELSE currently prints a higher short-term Unified Composite Score (57.3/100 HOLD vs. KEQU 37.8/100 SELL), KEQU captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (5.4% vs. -8.5% operating margin) and revenue trajectory (-6.7% vs. +15.2% YoY).
  • Technical & Structure Timing Caution: ELSE trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 68.4); meanwhile KEQU is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ELSE vs KEQU
ELSE NASDAQ
Electro-Sensors Inc
Industrial Instruments For Measurement, Display, And Control
$7.74
+0.0% 1D
Market Cap $27.3M
TTM Revenue $10M
Forward P/E 14.7x
Beta / 30D Vol 0.28β · 2% Vol
Unified Composite Score
57.3 / 100 HOLD
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 68
RSI-14: 68.4 · SMA20: $7.71 · SMA50: $7.69
KEQU NASDAQ Head-to-Head Winner
Kewaunee Scientific Corp
Laboratory Apparatus & Furniture
$33.55
-2.75% 1D
Market Cap $99.9M
TTM Revenue $277M
Forward P/E 7.7x
Beta / 30D Vol 0.33β · 38% Vol
Unified Composite Score
37.8 / 100 SELL
Tech 48.0 Fund 49.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -2.9%) with fading momentum, RSI 47
RSI-14: 46.7 · SMA20: $34.06 · SMA50: $33.87

6-Pillar Scorecard Institutional Category Breakdown (ELSE 1 – 4 KEQU)

Columns: Metric · ELSE · KEQU
1. Valuation Multiples KEQU
Forward P/E 14.7x 7.7x
Trailing P/E 96.8x 12.5x
PEG Ratio 3.15x N/M
EV / Revenue 2.6x 0.4x
2. Growth & Scale KEQU
Revenue Growth (YoY) +15.2% -6.7%
Earnings Growth (YoY) -49.1% -44.2%
TTM Revenue (USD) $10M $277M
Market Cap $27.3M $99.9M
3. Profitability & Quality KEQU
Gross Margin 51.5% 28.6%
Operating Margin -8.5% 5.4%
Net Profit Margin 2.4% 3.0%
Return on Equity (ROE) 1.7% 12.5%
4. Balance Sheet & Cash Flow KEQU
Cash Generation (TTM) $667,000 $21M EBITDA
Cash Flow Margin 6.4% 7.7% EBITDA Mgn
Net Cash / Leverage $4.22 Book/Sh · 1.7% ROE $25.91 Book/Sh · 12.5% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Distribution
6. R&D & Supply-Chain Moat ELSE
OpEx & R&D Intensity 60.0% of Rev ($6.3M) 23.2% of Rev ($64M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Scientific & Technical Instruments Operator Furnishings, Fixtures & Appliances Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ELSE (4) vs KEQU (6)
Institutional Metric ELSE KEQU Criterion Row Edge
Market Capitalization
Scale
$27.3M $99.9M Larger Scale KEQU
Trailing P/E Ratio
Valuation
96.8x 12.5x Lower Multiple KEQU
Forward P/E Ratio
Valuation
14.7x 7.7x Lower Multiple KEQU
Revenue Growth (YoY)
Growth
+15.2% -6.7% Higher Growth ELSE
Operating Margin (TTM)
Profitability
-8.5% 5.4% Higher Margin KEQU
Net Profit Margin
Profitability
2.4% 3.0% Higher Margin KEQU
Return on Equity (ROE)
Capital Efficiency
1.7% 12.5% Higher ROE KEQU
52-Week Range Position
Momentum
100% ($4–$8) 14% ($32–$43) Stronger Trend ELSE
Beta / 30D Volatility
Risk Regime
0.28β · 2% Vol 0.33β · 38% Vol Lower Realized Risk ELSE
Unified Institutional Score
Composite Signal
57.3 / 100 (HOLD) 37.8 / 100 (SELL) Higher Composite ELSE
Trailing 12M Revenue (USD)
Operating Scale
$10M $277M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
51.5% 28.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
3.15x PEG · 2.6x EV/Rev N/M PEG · 0.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$667,000 ($4.22 Book/Sh · 1.7% ROE) $21M EBITDA ($25.91 Book/Sh · 12.5% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon KEQU +2.67 pp
ELSE: +1.05% · KEQU: +3.72%
3M Horizon ELSE +2.21 pp
ELSE: +1.44% · KEQU: -0.77%
6M Horizon ELSE +78.91 pp
ELSE: +77.12% · KEQU: -1.79%
1Y Horizon ELSE +70.14 pp
ELSE: +61.1% · KEQU: -9.04%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ELSE vs KEQU. Trailing 12-month operating profitability (ELSE -8.5% vs KEQU 5.4%) and valuation multiples (ELSE 14.7x vs KEQU 7.7x Forward P/E) are benchmarked directly in Pillar 4 below.

ELSE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$10M
Gross Margin51.5%
Op. Margin-8.5%
ROE / Fwd P/E1.7% · 14.7x
KEQU ADR TTM Benchmark FX-Normalized USD
TTM Revenue$277M
Gross Margin28.6%
Op. Margin5.4%
ROE / Fwd P/E12.5% · 7.7x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ELSE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ELSE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
KEQU UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KEQU Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ELSE Moat Profile Cyclical / Execution-Driven Positioning
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $27.3M market capitalization and -8.5% operating margin.
OpEx & R&D Reinvestment 60.0% of Rev ($6.3M)
90D Engineering Disclosures 0 Published
KEQU Moat Profile Cyclical / Execution-Driven Positioning
Furnishings, Fixtures & Appliances Operator
Competes within the Furnishings, Fixtures & Appliances value chain with $99.9M market capitalization and 5.4% operating margin.
OpEx & R&D Reinvestment 23.2% of Rev ($64M)
90D Engineering Disclosures 0 Published

Investor FAQ ELSE vs KEQU Key Questions & Quantitative Answers

As of Nov 20, 2026, Kewaunee Scientific Corp (KEQU) is the stronger overall head-to-head candidate over Electro-Sensors Inc (ELSE) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ELSE carries a Unified Composite Score of 57.3/100 (HOLD) at $7.74 (14.7x Forward P/E, -8.5% operating margin), whereas KEQU carries 37.8/100 (SELL) at $33.55 (7.7x Forward P/E, 5.4% operating margin). Composite vs. Pillar Nuance: While ELSE currently prints a higher short-term Unified Composite Score (57.3/100 HOLD vs. KEQU 37.8/100 SELL), KEQU captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (5.4% vs. -8.5% operating margin) and revenue trajectory (-6.7% vs. +15.2% YoY). Technical & Structure Timing Caution: ELSE trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 68.4); meanwhile KEQU is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

KEQU leads the Growth & Scale pillar: ELSE posts +15.2% YoY revenue growth and -49.1% YoY earnings growth on $10M TTM revenue (51.5% gross margin, -8.5% operating margin), compared with KEQU at -6.7% YoY revenue growth and -44.2% YoY earnings growth on $277M TTM revenue (28.6% gross margin, 5.4% operating margin). On trailing 12-month operating scale, ELSE generates $10M in USD-normalized revenue versus $277M for KEQU. In operating R&D and SG&A reinvestment, ELSE deploys 60.0% of Rev ($6.3M) (0 90-day corporate R&D disclosures) versus 23.2% of Rev ($64M) (0 disclosures) for KEQU.

KEQU screens cheaper on headline valuation multiples. ELSE trades at 14.7x Forward P/E, 96.8x Trailing P/E, 3.15x PEG, and 2.6x EV/Revenue (6.4% FCF margin), whereas KEQU trades at 7.7x Forward P/E, 12.5x Trailing P/E, N/M PEG, and 0.4x EV/Revenue (7.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ELSE (1.7% ROE) versus KEQU (12.5% ROE) capital efficiency.

In options market volatility and institutional positioning, ELSE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.28β · 2% Vol realized risk). By comparison, KEQU carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.33β · 38% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.